BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1465969)

  • 1. Prevention of recurrence of insulin-dependent diabetes mellitus in islet cell-transplanted diabetic NOD mice using adjuvant therapy.
    Lakey JR; Wang T; Warnock GL; Singh B; Rajotte RV
    Transplant Proc; 1992 Dec; 24(6):2848. PubMed ID: 1465969
    [No Abstract]   [Full Text] [Related]  

  • 2. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of diabetes incidence by intrathymic islet isografting in newborn NOD mice.
    Nomura Y; Stein E; Mullen Y
    Transplant Proc; 1992 Dec; 24(6):2903. PubMed ID: 1465992
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant immunotherapy with Bacillus Calmette-Guerin prevents recurrence of diabetes in islet grafts transplanted into NOD mice.
    Lakey JR; Warnock GL; Singh B; Rajotte RV
    Transplant Proc; 1994 Apr; 26(2):736. PubMed ID: 8171632
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose dependence of bacillus Calmette-Guerin on the prevention of autoimmune diabetes in syngeneic islet transplantation.
    Lakey JR; Singh B; Warnock GL; Elliott JF; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3413. PubMed ID: 8540025
    [No Abstract]   [Full Text] [Related]  

  • 6. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreas transplantation: is islet transplantation the future?
    Fernandez-Cruz L; Casanovas D; Lloveras G
    Transplant Proc; 1992 Dec; 24(6):2379-82. PubMed ID: 1465802
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of recurrent autoimmune islet transplant destruction by simultaneous kidney transplantation.
    Bartlett ST; Dirden B; Schweitzer EJ; Sheffield C; Hadley GA
    Transplant Proc; 1994 Apr; 26(2):737. PubMed ID: 8171633
    [No Abstract]   [Full Text] [Related]  

  • 10. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
    Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-2 Microglobulin gene disruption prolongs murine islet allograft survival in NOD mice.
    Osorio RW; Ascher NL; Melzer JS; Stock PG
    Transplant Proc; 1994 Apr; 26(2):752. PubMed ID: 8171644
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
    Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
    Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
    Hu C; Deng S; Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.
    Nishio J; Gaglia JL; Turvey SE; Campbell C; Benoist C; Mathis D
    Science; 2006 Mar; 311(5768):1775-8. PubMed ID: 16556845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine.
    Mathieu C; Laureys J; Waer M; Bouillon R
    Transplant Proc; 1994 Dec; 26(6):3128-9. PubMed ID: 7998092
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relationship between the expression of bcl-2 and proliferation cell nuclear antigen in islet cells and prevention of complete Freund's adjuvant on insulitis and diabetes in nonobese diabetic mice].
    Yang Z; Wu H; Zhou Z
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(6):587-9. PubMed ID: 12080732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.